Eric Andrew Collisson
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
Papers in
- Oncology 32
- Pancreatic and Hepatic Oncology Research 26
- Cancer Immunotherapy and Biomarkers 3
-
- Cancer Genomics and Diagnostics 15
- Co-authors
- Ilya Shmulevich C (1 shared paper)John N. Weinstein (1 shared paper)Gordon Brent Mills (1 shared paper)Kyle Ellrott (1 shared paper)Chris Sander (1 shared paper)Brad Ozenberger (1 shared paper)Joshua M. Stuart (1 shared paper)Kenna R Mills Shaw (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (7 papers)Nature Medicine (4 papers)Nature (4 papers)Cancer Discovery (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Eric Andrew Collisson
85 papers receiving 27.1k citations
Eric Andrew Collisson's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 6k
- Oncology 8.7k
- Pulmonary and Respiratory Medicine 5.2k
- Molecular Biology 8.3k
- Cell Biology 890
Countries citing papers authored by Eric Andrew Collisson
This map shows the geographic impact of Eric Andrew Collisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Andrew Collisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Andrew Collisson more than expected).
Fields of papers citing papers by Eric Andrew Collisson
This network shows the impact of papers produced by Eric Andrew Collisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Andrew Collisson. The network helps show where Eric Andrew Collisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Andrew Collisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Cancer Genome Atlas Pan-Cancer analysis project Hit paper breakdown → | 2013 | 6389 |
| 2 | Comprehensive molecular profiling of lung adenocarcinoma Hit paper breakdown → | 2014 | 4597 |
| 3 | Comprehensive genomic characterization of squamous cell lung cancers Hit paper breakdown → | 2012 | 3326 |
| 4 | Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 1585 |
| 5 | Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Hit paper breakdown → | 2011 | 1475 |
| 6 | Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy Hit paper breakdown → | 2014 | 975 |
| 7 | Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas Hit paper breakdown → | 2016 | 963 |
| 8 | A colorectal cancer classification system that associates cellular phenotype and responses to therapy Hit paper breakdown → | 2013 | 810 |
| 9 | Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors Hit paper breakdown → | 2015 | 655 |
| 10 | Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA Hit paper breakdown → | 2015 | 599 |
| 11 | Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression Hit paper breakdown → | 2016 | 497 |
| 12 | The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Hit paper breakdown → | 2015 | 468 |
| 13 | 2011 | 386 | |
| 14 | 2011 | 381 | |
| 15 | 2019 | 347 | |
| 16 | 2012 | 261 | |
| 17 | 2015 | 241 | |
| 18 | 2015 | 237 | |
| 19 | 2013 | 230 | |
| 20 | 2015 | 224 |
About Eric Andrew Collisson
Eric Andrew Collisson is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 86 papers that have together received 27.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (26 papers), Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (12 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), AI in cancer detection (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Cancer Research (6k citations), Oncology (8.7k citations), Pulmonary and Respiratory Medicine (5.2k citations), Molecular Biology (8.3k citations) and Cell Biology (890 citations). Eric Andrew Collisson has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Ilya Shmulevich C, John N. Weinstein, Gordon Brent Mills, Kyle Ellrott, Chris Sander, Brad Ozenberger, Joshua M. Stuart, Kenna R Mills Shaw, Joe W. Gray and Adam B. Olshen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine, Nature, Cancer Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.